| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8445650 | European Journal of Cancer | 2012 | 8 Pages |
Abstract
The IGF pathway is deregulated in GIST with distinct patterns according to age onset and mutational status. The IGF pathway may represent a therapeutic target in patients with primary or secondary resistance to imatinib.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Antoine Italiano, Junwei Chen, Lei Zhang, Mihai Hajdu, Samuel Singer, Ronald P. DeMatteo, Cristina R. Antonescu,